PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Sipuleucel-T in prostate cancer: Indication of added benefit

Data and analyses subsequently submitted by the drug manufacturer provided better evidence on mortality

2015-03-20
(Press-News.org) Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or no symptoms and do not yet require chemotherapy. In the dossier assessment conducted by the German Institute for Quality and Efficiency in Health Care (IQWiG) in January 2015, no added benefit could be derived for sipuleucel-T.

In an addendum, the Institute now examined information subsequently submitted by the manufacturer in the commenting procedure: According to the findings, there is an indication of added benefit; however, the extent is non-quantifiable.

Mortality: data in the dossier incomplete and not interpretable

Treatment switching occurred in all three approval studies comparing sipuleucel-T with placebo, which were presented in the dossier by the manufacturer: More than two thirds of the patients in the placebo group started treatment with sipuleucel-T on progression of their disease. In both study arms, patients received chemotherapy with docetaxel on progression. The proportion of patients who received docetaxel and the time point of this treatment differed, however, and the respective information provided in the dossier was incomplete.

The study results on overall survival in the dossier could therefore not be interpreted in a meaningful way: Docetaxel has a positive effect on survival. If, for example, it is given at an earlier time point in the sipuleucel-T arm than in the control arm, lower mortality cannot be explained solely by the effect of sipuleucel-T. Then there is a risk of overestimating the effect of sipuleucel-T.

Additional analyses showed advantage in mortality

The manufacturer presented further data and sensitivity analyses on overall survival with its comment. This now led to a consistent picture in comparison with the primary analysis of the data in the dossier: According to this, the lower mortality in the sipuleucel-T arms cannot be explained solely by differences in the administration of docetaxel after progression.

However, the advantages in overall survival are accompanied by negative effects in the form of side effects: Fever, headache and chills were more frequent in patients in the sipuleucel-T arm. However, these side effects were non-serious and mainly occurred only directly after the administration of sipuleucel-T. IQWiG therefore did not downgrade the positive effect regarding mortality. The conclusion of the addendum for sipuleucel-T is therefore an indication of an added benefit with the extent "non-quantifiable".

G-BA decides on the extent of added benefit

The dossier assessment is part of the early benefit assessment according to the Act on the Reform of the Market for Medicinal Products (AMNOG) supervised by the G-BA. After publication of the manufacturer's dossier and the IQWiG dossier assessment, the manufacturer submitted additional information in the commenting procedure. The G-BA subsequently commissioned IQWiG to assess the data subsequently submitted. IQWiG now presents this assessment in the form of an addendum. The G-BA makes a final decision on the extent of added benefit.

INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Adapting to climate change will bring new environmental problems

2015-03-20
Adapting to climate change could have profound environmental repercussions, according to a new study from the University of East Anglia. Research in Nature Climate Change reveals that adaptation measures have the potential to generate further pressures and threats for both local and global ecosystems. Lead researcher Dr Carlo Fezzi, from UEA's School of Environmental Sciences, said: "Climate change is a just a little bit more complicated than we previously thought. We need to take into account not only the direct impact of climate change, but also how people will respond ...

Scientists must reduce antibiotic use in experiments

2015-03-20
Scientists should reduce antibiotic use in lab experiments - according to a researcher at the University of East Anglia. Microbiology, molecular biology and genetic research such as the Human Genome Project use antibiotics in experiments. But it all adds to the global problem of antibiotic resistance according to Dr Laura Bowater, from UEA's Norwich Medical School. A new article published today in the Journal of Antimicrobial Chemotherapy highlights the problem. Dr Bowater said: "The discovery of antibiotics was heralded as a magic bullet for modern medicine. Using ...

The Oldest Old are changing Canada

2015-03-20
This news release is available in French. In 1971 there were 139,000 Canadians aged 85 and over. By 2013 their numbers had risen to 702,000. The Oldest Old as they have become known today represent 2% of the total Canadian population. "They are a demographic reality which has to be taken into account in formulating public policy", according to Jacques Légaré, a demographer at the University of Montreal, who is presenting a report on this phenomenon this week to more than a hundred experts meeting at the Population Change and Lifecourse Strategic Knowledge ...

Suspension leads to more pot use among teens, study finds

2015-03-20
Suspending kids from school for using marijuana is likely to lead to more -- not less -- pot use among their classmates, a new study finds. Counseling was found to be a much more effective means of combating marijuana use. And while enforcement of anti-drug policies is a key factor in whether teens use marijuana, the way schools respond to policy violators matters greatly. The study, conducted by researchers at the University of Washington and in Australia, compared drug policies at schools in Washington state and Victoria, Australia, to determine how they impacted ...

Bright new hope for beating deadly hereditary stomach and breast cancers

2015-03-20
Deadly familial stomach and lobular breast cancers could be successfully treated at their earliest stages, or even prevented, by existing drugs that have been newly identified by cancer genetics researchers at New Zealand's University of Otago. The researchers, led by Professor Parry Guilford, show for the first time that the key genetic mutation underlying the devastating conditions also opens them to attack through drug therapies targeting other cellular mechanisms. There is currently no treatment for this kind of gastric cancer other than surgical removal of the ...

Thinking of drinking and driving? What if your car won't let you?

Thinking of drinking and driving? What if your car wont let you?
2015-03-20
ANN ARBOR, Mich. -- If every new car made in the United States had a built-in blood alcohol level tester that prevented impaired drivers from driving the vehicle, how many lives could be saved, injuries prevented, and injury-related dollars left unspent? Researchers at the University of Michigan Injury Center and the University of Michigan Transportation Research Institute studied the impact of installing these alcohol ignition interlock devices in all newly purchased vehicles over a 15-year period; their estimates of injury prevention and cost savings are significant. They ...

Healthy grain fiber helps barley resist pests

2015-03-20
Research at the University of Adelaide's Waite campus has shed light on the action of the serious agricultural pest, cereal cyst nematode, which will help progress improved resistant varieties. Published in the journal New Phytologist, the researchers showed how the composition of the cell wall that surrounds the feeding sites of these tiny parasitic worms in the plant roots differs between resistant and susceptible varieties of barley. "A type of fibre that we usually associate with wholegrain and healthy foods ? beta-glucan ? accumulates in the cell walls surrounding ...

Review of global guidelines for sepsis needed

2015-03-20
Experts are calling for a global review of guidelines used to diagnose sepsis, after a study found one in eight patients with infections severe enough to need admission to an Intensive Care Unit in Australia and New Zealand, did not meet current criteria. Researchers from Monash University and the Australian and New Zealand Intensive Care Society (ANZICS) reviewed data collected on over a million patients admitted to 172 Intensive Care Units (ICU). Covering a 14-year period, 109,663 patients with infection and organ failure were identified with possible sepsis. However, ...

Superfast computers a step closer as a silicon chip's quantum capabilities are improved

2015-03-20
The team demonstrated a quantum on/off switching time of about a millionth of a millionth of a second - the fastest-ever quantum switch to be achieved with silicon and over a thousand times faster than previous attempts. "Quantum computing exploits the fact that, according to quantum mechanics atoms can exist in two states at once, being both excited and unexcited at the same time. This is known as a superposition state, and is most famously illustrated by Schrödinger's quantum cat which is simultaneously dead and alive" said Dr. Ellis Bowyer, one of the Surrey ...

Autistic and non-autistic brain differences isolated for first time

Autistic and non-autistic brain differences isolated for first time
2015-03-20
New big data methodology can analyse over 1 billion pieces of data The methodology can potentially isolate the areas of the brain involved with other cognitive problems, including Obsessive Compulsive Disorder, ADHD and schizophrenia. The functional differences between autistic and non-autistic brains have been isolated for the first time, following the development of a new methodology for analysing MRI scans. Developed by researchers at the University of Warwick, the methodology, called Brain-Wide Association Analysis (BWAS), is the first capable of creating panoramic ...

LAST 30 PRESS RELEASES:

Targeting specific protein regions offers a new treatment approach in medulloblastoma

$2.7 million grant to explore hypoxia’s impact on blood stem cells

Cardiovascular societies propel plans forward for a new American Board of Cardiovascular Medicine

Hebrew SeniorLife selected for nationwide collaborative to accelerate system-wide spread of age-friendly care for older adults

New tool helps identify babies at high-risk for RSV

Reno/Sparks selected to be part of Urban Heat Mapping Campaign

Advance in the treatment of acute heart failure identified

AGS honors Dr. Rainier P. Soriano with Dennis W. Jahnigen Memorial Award at #AGS24 for proven excellence in geriatrics education

New offshore wind turbines can take away energy from existing ones

Unprecedented research probes the relationship between sleep and memory in napping babies and young children

Job losses help explain increase in drug deaths among Black Americans

Nationwide, 32 local schools win NFL PLAY 60 grants for physical activity

Exposure to noise – even while in the egg – impairs bird development and fitness

Vitamin D availability enhances antitumor microbes in mice

Conservation actions have improved the state of biodiversity worldwide

Corporate emission targets are incompatible with global climate goals

Vitamin D alters mouse gut bacteria to give better cancer immunity

Escape the vapes: scientists call for global shift to curb consumer use of disposable technologies

First-of-its-kind study definitively shows that conservation actions are effective at halting and reversing biodiversity loss

A shortcut for drug discovery

Food in sight? The liver is ready!

Climate change could become the main driver of biodiversity decline by mid-century

Voluntary corporate emissions targets not enough to create real climate action

Curiosity promotes biodiversity

Warming Arctic reduces dust levels in parts of the planet

New MSU research finds paid family leave helps prevent child abuse

Endocrine Society names Andrews as new Editor-in-Chief of Endocrinology

Type of surgery and its risk level has significant impact on complications and death in elderly patients

National Center to Reframe Aging teams up with Longevity Ready Maryland Initiative

Study reveals racial disparities in COVID-19 testing delays among healthcare workers

[Press-News.org] Sipuleucel-T in prostate cancer: Indication of added benefit
Data and analyses subsequently submitted by the drug manufacturer provided better evidence on mortality